Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081-Reference-Cited by-同舟云学术

Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081

Published:2022-12-01 Issue:4 Volume:91 Page:403-409
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Coutinho Conrado Milani,Warshaw Meredith G.,Duarte Geraldo,Stek Alice,Violari Avy,Hofer Cristina B.,Deville Jaime G.,Ngocho James Samwel,Pilotto José Henrique,Correa Mario Dias,Shapiro David E.,Fuller Trevon L.,Chakhtoura Nahida,Mirochnick Mark,João Esaú C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference32 articles.

1. Raltegravir pharmacokinetics during pregnancy;Watts;J Acquir Immune Defic Syndr.,2014

2. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial;João;Lancet HIV,2020

3. Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women;Brites;HIV Clin Trials,2018

4. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial;Venter;Lancet HIV,2020

5. Dolutegravir-based or low-dose efavirenz–based regimen for the treatment of HIV-1;Mpoudi-Etame;N Engl J Med.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women;Expert Opinion on Drug Metabolism & Toxicology;2024-05-14

2. Cardiometabolic Health in Pregnancy and Postpartum: Findings From a Prospective Cohort Study in South Africa;Open Forum Infectious Diseases;2024-02-22

3. Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum;Clinical Infectious Diseases;2024-01-05

4. Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV;New England Journal of Medicine;2023-01-26